Malaria Diagnostics Market

Global Malaria Diagnostics Market Size (2023 to 2028)

The global malaria diagnostics market is expected to grow at a CAGR of 6.22% from 2023 to 2028 and be worth USD 1.18 billion by 2028 from USD 0.87 billion in 2023.

Global Malaria Diagnostics Market Share Insights:

• Based on technology, the microscopy segment led the market in 2022.
• Based on end-user, the clinics segment had the major share of the global market in 2022.
• Based on region, North America held the largest share of the worldwide market in 2022.

Impact of COVID-19 on the global malaria diagnostics market:

The global malaria diagnostics market was significantly affected by the COVID-19 pandemic. The production and distribution of malaria diagnostic tests faced significant challenges due to supply chain disruptions. This resulted in substantial delays and shortages, particularly in regions heavily affected by COVID-19 and malaria. As a result, maintaining an adequate supply of testing tools posed a significant challenge. The COVID-19 pandemic also caused a diversion of healthcare resources and attention, declining routine malaria testing and surveillance efforts. However, the malaria diagnostics market experienced some positive changes as well. The COVID-19 pandemic's pressing demand for diagnostic testing has resulted in the accelerated development and deployment of rapid diagnostic tests (RDTs) and molecular diagnostic tools, indirectly contributing to advancements in malaria diagnostics.

MARKET DRIVERS:

The prevalence of malaria in endemic regions is one of the key factors driving the global market for malaria diagnostics. Sub-Saharan Africa and other regions continue to experience a significant number of malaria cases and fatalities. According to the World Health Organization (WHO), in 2019, Africa accounted for 94% of all malaria cases and fatalities worldwide. The high prevalence of malaria in these regions creates a substantial demand for accurate and accessible diagnostic tools to detect and manage the disease effectively.

Government initiatives and funding also play a significant role in market growth. These initiatives aim to increase access to diagnostic testing, strengthen healthcare systems, and promote research and development in malaria diagnostics. For instance, the World Health Organization's (WHO) Global Malaria Programme guides and aids nations in preventing, diagnosing, and treating malaria.

Technological advancements have substantially impacted the malaria diagnostics market. Innovations in diagnostic technologies have resulted in the creation of more precise, sensitive, and user-friendly diagnostic tests. Rapid diagnostic tests (RDTs) have acquired popularity due to their ease of use, rapid results, and suitability in settings with limited resources. Collaborations and partnerships among various market participants propels the market growth. The development and deployment of malaria diagnostic instruments have been accelerated by public-private partnerships, research collaborations, and partnerships between governments and non-profit organisations. These partnerships combine expertise, resources, and funding to address obstacles and increase accessibility to effective diagnostics.

MARKET RESTRAINTS:

In malaria-endemic regions, especially in low-income countries, inadequate healthcare infrastructure hinders the effective implementation of diagnostic tests. Inadequate laboratories and trained personnel can result in delays, restricted access to diagnostics, and weaker quality control. The challenges of affordability and accessibility are significant hindrances, especially in areas with scarce resources, where diagnostic examinations can be expensive and pose logistical challenges. The presence of false-negative and false-positive outcomes represents an additional constraint, which highlights the need to implement quality control procedures to guarantee precision and reliability. The detection of drug-resistant malaria parasites poses a challenge to diagnosis, as conventional methods may not be sufficiently sensitive to identify resistance.

REPORT COVERAGE: 

This research report on global malaria diagnostics market has been segmented and sub-segmented based on the following categories.

Malaria Diagnostics Market - By Technology:

• Microscopy
• Rapid Diagnostic Tests
• Molecular Diagnostic Tests

Based on technology, the microscopy segment is expected to grow the fastest in the malaria diagnostics market over the forecast period as it is a tried-and-true method of diagnosing diseases. While molecular diagnostics have gained prominence in recent years, microscopy-based tests still hold significant importance, particularly in resource-limited settings where advanced technologies may not be readily available or affordable. The diagnosis of malaria by microscopy is a well-established method that is not overly complicated and is commonplace among those who work in laboratories. Due to the fact that it is able to deliver useful results within a few hours after blood is drawn, this diagnostic method is put to great use in the process of diagnosing malaria. According to WHO, more than 204 million microscopic malarial exams have been conducted worldwide.

The rapid diagnostic tests segment is expected to account for a considerable share of the global market during the forecast period. The growing demand for quick and reliable malaria diagnosis, especially in remote and underserved regions, increasing number of initiatives from governments initiatives to combat malaria and advancements in RDT technology drive the growth of the rapid diagnostic tests segment in the worldwide market.

The molecular diagnostic tests segment is anticipated to register a healthy CAGR in the coming years owing to the growing focus on eliminating malaria in certain regions that necessitate the accurate and sensitive diagnostic tools for surveillance and detection. Research and development efforts to improve molecular diagnostic techniques and rising use of molecular diagnostics for monitoring drug resistance and treatment efficacy in malaria-endemic regions further boost the growth rate of the molecular diagnostic tests segment in the global market.

Malaria Diagnostics Market - By End User:

• Hospitals
• Clinics
• Diagnostics Centers
• Others

Based on the end user, the clinics segment is anticipated to hold a substantial share of the global market during the forecast period. As a result of the growing number of clinics all over the world, it is anticipated that the clinics will capture a greater part of the market than other segments. In addition, the increasing need for early detection of falciparum malaria for improved healthcare treatment and the launch of modern diagnostics facilities are anticipated to considerably drive the market expansion throughout the forecast period.

Malaria Diagnostics Market - By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

The Middle East and Africa region led the global malaria diagnostics market and is expected to retain its dominance in the market over the forecast period. This can be attributed to the increasing cases of malaria in the region over the years. The World Health Organization's (WHO) increasing focus on reducing malaria fatality rates in African nations will fuel the market. According to World Health Organisation figures from July 2022, Sub-Saharan Africa is anticipated to continue to bear the burden of malaria, accounting for around 95% of all cases and 96% of all fatalities. As a result, it is expected that demand for malaria diagnostics products would be strong in the region over the projection period. Furthermore, the growing requirement for early detection and improved knowledge about malaria diagnosis are projected to drive demand for malaria diagnostics in this region.

KEY MARKET PLAYERS:

Abbott Laboratories, BioMérieux SA, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Cepheid, Inc., Siemens Healthineers, Roche Diagnostics, Ortho Clinical Diagnostics, Sysmex Corporation, Premier Medical Corporation, Beckman Coulter, Inc., Access Bio, Inc., Alere Inc., Thermo Fisher Scientific Inc., Hologic, Inc., Meridian Bioscience, Inc., Mologic Ltd., Rapid Diagnostic Pvt. Ltd., Partec GmbH and SD Biosensor, Inc. are some of the major companies in the global malaria diagnostics market.

RECENT HAPPENINGS IN THE MARKET:

• In June 2023, according to a study, a mosquito AgTRIO mRNA vaccine aids in malaria protection. Active or passive immunisation against a mosquito saliva protein, AgTRIO, contributes to protection against Plasmodium infection in mice. AgTRIO mRNA-LNP immunised mice exposed to Plasmodium-infected mosquitoes had markedly reduced initial Plasmodium hepatic infection levels and increased survival compared to control mice.